AlzChem H1 FY26 EBITDA climbs 14% to EUR 64.5 million; revenue rises 6% to EUR 303.9 million

Reuters2026/07/30 04:55

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

AlzChem posted H1 2026 revenue up 6% to EUR 303.9 million.
EBITDA climbed 14% to EUR 64.5 million; the EBITDA margin widened 1.6 percentage points to 21.2%.
Specialty Chemicals revenue rose 10% to EUR 214.3 million; EBITDA increased 19% to EUR 64.1 million.
Basics & Intermediates revenue slipped 3.6% to EUR 75.4 million; EBITDA swung to break-even.
Outlook for 2026 reiterated; new long-term financing agreed for up to EUR 100 million to fund growth projects.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AlzChem Group AG published the original content used to generate this news brief on July 30, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

AlzChem H1 FY26 EBITDA climbs 14% to EUR 64.5 million; revenue rises 6% to EUR 303.9 million

You may also like

Crypto prices